| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.14 | 0.006 |